Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Théa Nordic AB
Entity

Théa Nordic AB

Tracked across 1 events · 6 articles · First seen Aug 03, 2026 · Last active Aug 10, 2026

Sentiment
40
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
2 40
Tech
Dexamethasone eye drops reduce ROP treatment need
Researchers at the University of Gothenburg and Sahlgrenska University Hospital conducted the first randomized clinical trial testing dexamethasone eye drops to prevent treatment-requiring retinopathy of prematurity (ROP) in extremely premature infants. The DROPROP study enrolled…
Impact: Donated the dexamethasone product (Dexafree); positive trial results could increase demand for its product.
Aug 03, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Théa Nordic AB live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.